We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+19.59%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.49B
AUM Growth
+$149M
Cap. Flow
-$38.7M
Cap. Flow %
-1.56%
Top 10 Hldgs %
20.52%
Holding
268
New
26
Increased
99
Reduced
104
Closed
25

Top Buys

Rank Stock Value
1
LPX icon
Louisiana-Pacific
LPX
+$19.9M
2
LITE icon
Lumentum
LITE
+$15.1M
3
VKTX icon
Viking Therapeutics
VKTX
+$13.8M
4
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$12.7M
5
TREE icon
LendingTree
TREE
+$12M

Top Sells

Rank Stock Value
1
IMGN
Immunogen Inc
IMGN
+$51.7M
2
SMCI icon
Super Micro Computer
SMCI
+$47.1M
3
CBAY
Cymabay Therapeutics
CBAY
+$25.2M
4
PRVA icon
Privia Health
PRVA
+$14M
5
SMPL icon
Simply Good Foods
SMPL
+$13.6M

Sector Composition

Rank Sector Weight
1 Technology 25.01%
2 Healthcare 24.99%
3 Industrials 19.42%
4 Financials 9.95%
5 Consumer Discretionary 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VEEV icon
151
Veeva Systems
VEEV
$30.3B
$839K 0.03%
3,622
-60
-2% -$12.9K
MTD icon
152
Mettler-Toledo International
MTD
$26.8B
$803K 0.03%
603
-6
-1% -$7.4K
APO icon
153
Apollo Global Management
APO
$70.7B
$801K 0.03%
7,119
+4,288
+151% +$453K
LHX icon
154
L3Harris
LHX
$55.9B
$795K 0.03%
3,731
-61
-2% -$12.8K
COST icon
155
Costco
COST
$415B
$780K 0.03%
1,064
-105
-9% -$75K
OSW icon
156
OneSpaWorld
OSW
$2.67B
$767K 0.03%
57,950
+27,961
+93% +$378K
BMRN icon
157
BioMarin Pharmaceuticals
BMRN
$11.5B
$762K 0.03%
8,726
-5,724
-40% -$512K
KNSL icon
158
Kinsale Capital Group
KNSL
$7.95B
$751K 0.03%
1,431
+194
+16% +$87.6K
ICLR icon
159
Icon
ICLR
$12.8B
$750K 0.03%
2,233
-23
-1% -$6.78K
AMGN icon
160
Amgen
AMGN
$203B
$716K 0.03%
2,519
-183
-7% -$53.5K
APH icon
161
Amphenol
APH
$188B
$703K 0.03%
12,190
-204
-2% -$10.7K
ABT icon
162
Abbott
ABT
$180B
$689K 0.03%
6,060
-1,777
-23% -$204K
UBER icon
163
Uber
UBER
$134B
$681K 0.03%
8,841
-5,209
-37% -$374K
UNH icon
164
UnitedHealth
UNH
$382B
$663K 0.03%
1,340
-510
-28% -$259K
KEYS icon
165
Keysight
KEYS
$54.5B
$661K 0.03%
4,229
-69
-2% -$10.6K
AGS
166
DELISTED
PlayAGS
AGS
$651K 0.03%
72,464
+5,157
+8% +$45.1K
MPWR icon
167
Monolithic Power Systems
MPWR
$65.5B
$646K 0.03%
954
+238
+33% +$159K
EXPE icon
168
Expedia Group
EXPE
$31.2B
$625K 0.03%
4,537
+943
+26% +$134K
SPOT icon
169
Spotify
SPOT
$99.2B
$605K 0.02%
2,294
-37
-2% -$8.69K
TTD icon
170
Trade Desk
TTD
$8.13B
$601K 0.02%
6,876
-114
-2% -$8.64K
MSCI icon
171
MSCI
MSCI
$40B
$600K 0.02%
1,070
-12
-1% -$6.75K
SCHW
172
Charles Schwab
SCHW
$177B
$591K 0.02%
8,176
-3,123
-28% -$206K
TSLA icon
173
Tesla
TSLA
$1.24T
$577K 0.02%
3,281
-2,007
-38% -$392K
LLY icon
174
Eli Lilly
LLY
$1.07T
$566K 0.02%
728
-69
-9% -$49.1K
REGN icon
175
Regeneron Pharmaceuticals
REGN
$68.8B
$538K 0.02%
559
-53
-9% -$50.4K
5 6
7
8 9

Similar funds

FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FAM
Foxhaven Asset Management Charlottesville, Virginia $3.19B AUM 12.34% 1-Year Est. Return

Emerald Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, Emerald Advisers held 268 positions worth $2.49B, up 6.4% from $2.34B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Emerald Advisers's Q1 2024 filing shows 26 new, 99 increased, 104 reduced and 25 closed positions. Its largest new stake was Louisiana-Pacific: 276,306 shares worth $23.2M. The largest sale was Immunogen Inc, an estimated $51.7M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.

  • Emerald Advisers's largest Q1 2024 buy was Louisiana-Pacific: 276,306 shares worth $23.2M.
  • Emerald Advisers added most to Madrigal Pharmaceuticals in Q1 2024, an estimated $12.7M increase.
  • Emerald Advisers's biggest Q1 2024 reduction was Super Micro Computer, cutting an estimated $47.1M.
  • Emerald Advisers fully exited Immunogen Inc in Q1 2024, selling an estimated $51.7M.
  • Emerald Advisers's ten largest holdings make up 21% of its $2.49B portfolio in Q1 2024.
  • Emerald Advisers opened 26 new positions and closed 25 in Q1 2024.
  • Emerald Advisers's portfolio value rose 6.4% quarter-over-quarter to $2.49B.

Based on Emerald Advisers's 13F filing for Q1 2024, filed 8 May 2024.